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Twenty years ago, the first mammal cloned from an adult 
somatic cell was presented to the 
world. Dolly the sheep was born 
from the transfer of  a nucleus taken 
from a mammary gland cell into an 
unfertilized, enucleated oocyte. This 
breakthrough, made at the Roslin 
Institute, University of  Edinburgh, 
had a phenomenal scientific, 
economic and ethical impact. It 
provided definitive answers to key 
questions of  the time: Is it possible 
to change cells from one tissue to 
another? (Yes) Can a nucleus from a 
single adult mammalian cell be re- 
programmed to form an entire new 
organism? (Yes)
Coming of  Age: The legacy of  Dolly 
at 20 celebrations were held in 
Edinburgh last September   2016.   
On   Thursday   the   1st    September   
2016   the   charismatic    scientific
communicator and author, Dr Kat 
Arney, hosted a public lecture. 
Professor Sir Ian Wilmut (University 
of  Edinburgh), Professor Angelika 
Schnieke (Technical University 
Munich, Germany) and Professor 
Shinya Yamanaka (Kyoto University, 
Japan) introduced to visitors who 
Dolly was and the impact this 
research had on future studies. After 
the three talks, members of  the 
public could quiz the speakers and 
local researchers on what work they 
are currently pursuing in the realm 
of  gene editing, developmental 
biology and regenerative medicine.
This event was followed by a 
scientific symposium held in the 
Roslin Institute on Friday the 
2nd September, which was jointly 
organised by the University of  
Edinburgh’s MRC   Scottish
Centre for Regenerative Medicine 
and the Roslin Institute. With over 
260 scientists from around the 
world in attendance, including 30 
undergraduate students sponsored 
by the Genetics Society, the 
impressive auditorium of  the Roslin 
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Institute was not large enough 
to contain all the delegates. To 
accommodate everybody, the event 
was streamed live into an overflow 
seminar room and lecture hall and 
to the Centre for Tropical Livestock 
Genetics and Health (CTLGH), a 
partner institution of  the Roslin 
Institute in Nairobi, Kenya.
Professor Sir Ian Wilmut opened 
the symposium giving a detailed 
view of  the historical events that led 
to Dolly’s cloning. He highlighted 
previous critical breakthroughs 
in understanding, from August 
Weismann’s first concept of  the 
continuity of  germ-plasm as the 
basis of  heredity to Hans Spemann’s 
famous cleavage experiments 
of  salamander eggs in which he 
used his daughter’s baby hair to 
demonstrate that the nucleus is 
critical for embryonic development. 
In the experiments that led later to 
the generation of  Dolly,  Professor 
Sir Ian Wilmut explained the crucial 
impact of  the cell cycle stage of  
both the  donor and the acceptor 
cell in determining the efficiency of  
nuclear transfers.
Cloning or somatic cell nuclear 
transfer (SCNT) remains the 
method of  choice to genetically 
engineer livestock, but we also 
heard of  the technical advances in 
genetic engineering in livestock 
which is allowing direct editing 
of  the animals without the need 
for cloning. The recent technology 
revolution in using genome editing 
nucleases has allowed to microinject 
these reagents directly into 1-cell 
embryos or zygotes to generate 
defined genetic alterations and 
thereby to circumvent cloning. 
Several speakers presented their 
work on livestock engineering. Cows 
have been engineered to produce 
milk with higher casein levels 
(better for cheese production) or 
undetectable β-lactoglobulin levels 
(which can cause milk allergy in 
infants, presented by Prof  Goetz 
Laible, AgResearch, New Zealand) 
while chicken ‘bioreactors’ have 
been produced that express high 
levels of  HER-2 antibodies in their 
eggs (Dr Lisa Herron, The Roslin 
Institute) for the treatment of  
breast cancers. The production 
of  better large animal models 
for multiple human diseases is 
driving much of  the translational 
biomedical research at Roslin and 
other institutions all over the world. 
Examples on how livestock genome 
editing can be used to generate 
pigs that are resistant to infectious 
agents (African Swine Fever virus, 
presented by Dr Chris Proudfoot) or 
to model different types of  human 
cancer in pigs have illustrated 
the power of  these new emerging 
technologies. A prime example 
how such models can advance our 
understanding of  mechanisms 
underlying cancer development in 
humans was the targeting of  the 
porcine Adenomatous polyposis 
coli (APC) gene which produced a 
faithful model of  human colorectal 
cancer (presented by Prof  Angelika 
Schnieke, Technical University of  
Munich).
During lunch, delegates were 
treated to poster presentations from 
emerging researchers in a foyer 
packed with energetic debate. There 
were also a number of  stands from 
the symposium sponsors lining the 
hall. After lunch, focus switched 
from livestock genetic engineering 
to regenerative medicine with 
research involving murine models 
and preclinical studies in humans. 
Nobel Prize Laureate for Medicine 
or Physiology 2012, Professor Shinya 
Yamanaka detailed the impact Dolly 
had in inspiring the generation 
of  induced pluripotent stem (iPS) 
cells. The fact that Dolly was cloned 
from a fully differentiated adult 
mammary cell nucleus was the first 
indication to the scientific world 
that reversion of  differentiated cells 
to a pluripotent stem cell like state 
was indeed possible.
The session that followed provided 
mechanistic insights into the process 
of  reversing differentiation and 
the applications of  this research. 
The current estimated cost of  
applying personalised medicine led 
several speakers to argue in favour 
of  the creation of  iPS libraries 
from healthy volunteers. Such 
iPS cells can be rigorously quality 
controlled and HLA matched for 
their therapeutic use in recipients 
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to avoid rejections of  transplanted 
iPS cells by the immune systems. 
Prof  Yamanaka showed that as 
few as 140 carefully selected iPS 
cell lines generated from donor 
peripheral blood or cord blood cells 
would be HLA compatible with 90% 
of  the Japan population (similar 
numbers are expected for Britain). 
How the ‘Yamanaka’ factors induce 
pluripotency at the chromatin level 
was presented by Dr  Abdenour 
Soufi and how cell lineage choices 
are impacted by morphological 
changes was presented by Dr 
Sally Lowell (both MRC Scottish 
Centre for Regenerative Medicine, 
University of  Edinburgh). A number 
of  speakers also discussed the use of  
differentiated iPS cells in generating 
patient derived disease models; 
an ideal model for testing possible 
therapeutics. 
Prof  Marius Wernig (Stanford 
University, USA) presented 
his findings how  skin derived 
fibroblasts can be converted 
into functional neurons. A 
screen undertaken in his lab has 
identified three factors critical in 
reprogramming fibroblast into 
neuronal cells that  can form 
functional synapses. He has now 
identified targets of  one factor and 
demonstrated that these orchestrate 
a repressive regulator program in 
neurons that suppress other cell 
lineage identities.
The last session of  the symposium 
focused on the development of  
therapeutic stem cell approaches 
for the clinic. Prof  Paul Tesar (Case 
Western Reverse University, Ohio, 
USA) discussed the role of  iPS 
cells in testing candidate drugs for 
patients with multiple sclerosis. 
Prof  Stuart Forbes (MRC Scottish 
Centre for Regenerative Medicine) 
gave new insights into mechanisms 
that control liver regeneration 
after severe injury discussing 
how impairment of  hepatocyte 
proliferation in these situations 
might be overcome. 
A big overarching theme of  this 
session was the usage of  organoids 
as cell culture models for studying 
specific mechanisms of  disease 
pathogenesis. Prof  Marc van de 
Wetering (Princess Maxima Center, 
Utrecht, Netherlands) demonstrated 
impressively how organoids can be 
grown from single multipotent stem 
cells to generate tissue structures 
that resemble key features of  organs. 
He discussed how organoid 
biobanks can be generated from 
patient biopsies and how these can 
be used for drug target discovery 
and therapy development. As 
an example, he showed how his 
laboratory is using intestinal 
organoids derived from colorectal 
cancer patients to identify drugs 
that specifically inhibit tumor 
growth in these patients. Prof  
Andrew Jackson (MRC Human 
Genetics Unit, University of  
Edinburgh) presented in his talk 
how brain organoids  can be used to 
study mechanisms of  microcephaly 
development. 
The organoids his laboratory is 
growing recapitulate early cortical 
brain development and can be 
used to dissect and to understand 
effects of  gene mutations that are 
associated with inheritable forms of  
microcephaly.
Ethical discussions where pervasive 
throughout the whole symposium. 
Although legislation may not 
be somewhat behind the latest 
technologies of  iPS cells and 
genetic editing, the potential for 
agricultural and medical application 
is overwhelmingly clear. Will cloning 
soon be part of  the solutions to the 
ageing population and sustainable 
food supply in times of   global 
population growth, diet changes 
and global warming? We are 
looking forward to answering that 
question at the Legacy of  Dolly at 40 
celebrations.
The video recordings of  Coming of  Age: The Legacy of  Dolly at 20 Scientific Symposium talks and the slide show of  
this event can be found on the following website: https://media.ed.ac.uk/channel/Dolly+at+20+Scientific+Symposium/
